Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr. Reddy's Laboratories informs about press release
Date: 17-10-2020Dr. Reddy's Laboratories has informed that it has enclosed press release titled ‘Dr. Reddy's and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India’.
The above information is a part of company’s filings submitted to BSE.